ARHGAP42-AS1

Across TCGA pan-cancer cohorts, ARHGAP42-AS1 RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated ARHGAP42-AS1 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher ARHGAP42-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated ARHGAP42-AS1 expression acts as an unfavorable survival marker, although some lineages such as KIRC and LGG show a favorable association.

KIRC, MESO, and LGG are the cancer types where ARHGAP42-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	OS	Quartile	All	0.898	0.802	.006	48	view →
MESO	OS	Median	All	0.274	0.494	.001	39	view →
LGG	OS	Tertile	All	0.936	0.829	<.001	34	view →
HNSC	OS	Tertile	IV	0.777	0.523	<.001	34	view →
READ	DFS	Median	All	0.770	0.245	.001	28	view →
ESCA	OS	Median	All	0.647	1.000	.015	21	view →
COAD	DFS	Median	All	0.716	0.861	.004	18	view →
SKCM	DFS	Median	IV	0.187	0.763	.006	16	view →
KIRP	OS	Median	II,III,IV	0.904	0.729	.008	13	view →
UCS	OS	Tertile	IV	0.241	0.783	.024	12	view →
LUSC	OS	Tertile	All	0.701	0.559	.005	12	view →
PAAD	OS	Tertile	All	0.308	0.501	.012	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 19 lineages.

ARHGAP42-AS1–KIRC (OS)

Open the KIRC breakdown →